Research progress in the molecular mechanisms of histone deacetylase inhibitors for radiosensitization / 中华放射医学与防护杂志
Jie GAO; Dianjun WEI; Jianfeng LIU; Chunhua REN.
Chinese Journal of Radiological Medicine and Protection
; (12): 465-468, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-910340
Radiotherapy is one of the most commonly used and effective method to treat malignant tumors in clinical practice. However, there are still some limitations including high radiotherapy doses, harmful side effects on normal tissues, and radiation resistance of tumor cells. Therefore, seeking safe and effective radiotherapy sensitizers to improve radiation sensitivity of tumor cells has been focused for a long time. Histone deacetylase inhibitors (HDACIs), as a kind of epigenetic modifiers, can regulate the sensitivity of tumor cells to ionizing radiation and ultraviolet radiation in addition to the inherent anticancer characteristics. This article reviewed the molecular mechanisms of HDACIs in enhancing radiation sensitivity and by selectively killing tumor cells.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados